Research progress of drug-induced osteoporosis
Wenbin Tan1,2, Ting He1,2, Jia Li3,4,5
1The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
None:
Drug-induced osteoporosis (DIO) is an important part of secondary osteoporosis. This article discusses the effects of common drugs on bone metabolism and the possible mechanisms leading to osteoporosis and discusses the possible treatment strategies. Although anti-osteoporosis drugs can effectively improve bone mineral density and reduce the risk of fracture and prevent the occurrence of DIO, long-term use of anti-osteoporosis drugs may lead to skeletal adverse events such as atypical femur fracture. Therefore, for the prevention and treatment of DIO, the benefits and adverse reactions of drugs should be comprehensively considered to develop an individualized treatment plan for patients.
More Related Videos
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:40Bone Remodeling
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...